Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Osada, Chisako Ito, Y. Nishiyama-Fujita, S. Ogura, A. Sakurai, M. Akimoto, Y. Aisa, T. Nakazato (2019)
Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant Lymphoma.Clinical lymphoma, myeloma & leukemia
I. Aird, H. Bentall, J. Roberts (1953)
Relationship Between Cancer of Stomach and the ABO Blood GroupsBritish Medical Journal, 1
Zhiwei Wang, Lei Liu, Jun-Tao Ji, Jia-nian Zhang, M. Yan, Jun Zhang, Bing-ya Liu, Zhenggang Zhu, Yingyan Yu (2012)
ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-AnalysisInternational Journal of Molecular Sciences, 13
M. Vadivelu, S. Damodaran, J. Solomon, A. Rajaseharan (2004)
Distribution of ABO blood groups in acute leukaemias and lymphomasAnnals of Hematology, 83
J. Beardmore, F. Karimi-Booshehri (1983)
ABO genes are differentially distributed in socio-economic groups in EnglandNature, 303
M. Breimer, J. Mölne, G. Nordén, L. Rydberg, G. Thiel, C. Svalander (2006)
Blood Group A and B Antigen Expression in Human Kidneys Correlated to A1/A2/B, Lewis, and Secretor StatusTransplantation, 82
T. Eastlund (1998)
The histo‐blood group ABO system and tissue transplantationTransfusion, 38
Juyi Li, Xiufang Wang, Jian Chen, Yi Cai, A. Deng, Ming-Wei Yang (2020)
Association between ABO blood groups and risk of SARS‐CoV‐2 pneumoniaBritish Journal of Haematology, 190
P. Moreau, J. Miguel, P. Sonneveld, M. Mateos, E. Zamagni, H. Avet-Loiseau, R. Hájek, M. Dimopoulos, H. Ludwig, H. Einsele, S. Zweegman, T. Facon, M. Cavo, E. Terpos, H. Goldschmidt, M. Attal, C. Buske (2017)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Annals of oncology : official journal of the European Society for Medical Oncology, 28 Suppl 4
Qiwen Ben, Kai-xuan Wang, Yao-zong Yuan, Zhaoshen Li (2011)
Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: A case–control studyInternational Journal of Cancer, 128
M. Varettoni, A. Corso, G. Pica, S. Mangiacavalli, C. Pascutto, M. Lazzarino (2010)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.Annals of oncology : official journal of the European Society for Medical Oncology, 21 2
M. Reid, N. Mohandas (2004)
Red blood cell blood group antigens: structure and function.Seminars in hematology, 41 2
Rashaduz Zaman, M. Parvez, Md Jakaria, M. Sayeed (2015)
Study of ABO and Rh-D blood group among the common people of Chittagong city corporation area of BangladeshJournal of public health and epidemiology, 7
M. Hughes, A. Doig, R. Soutar (2007)
Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patternsBritish Journal of Haematology, 137
Robert Kyle, S. Rajkumar (2007)
Epidemiology of the plasma-cell disorders.Best practice & research. Clinical haematology, 20 4
Robert Kyle, M. Gertz, T. Witzig, J. Lust, M. Lacy, A. Dispenzieri, R. Fonseca, S. Rajkumar, J. Offord, Dirk Larson, Matthew Plevak, Terry Therneau, P. Greipp (2003)
Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clinic proceedings, 78 1
L. Siransy, Z. Nanga, F. Zaba, Nyasenu Tufa, S. Dassé (2015)
ABO/Rh Blood Groups and Risk of HIV Infection and Hepatitis B Among Blood Donors of Abidjan, Côte D’ivoireEuropean Journal of Microbiology & Immunology, 5
A. Palumbo, H. Avet-Loiseau, S. Oliva, H. Lokhorst, H. Goldschmidt, L. Rosiñol, P. Richardson, S. Caltagirone, J. Lahuerta, T. Facon, S. Bringhen, F. Gay, M. Attal, R. Passera, A. Spencer, M. Offidani, Shaji Kumar, P. Musto, S. Lonial, M. Petrucci, R. Orlowski, E. Zamagni, G. Morgan, M. Dimopoulos, B. Durie, K. Anderson, P. Sonneveld, J. Miguel, M. Cavo, S. Rajkumar, P. Moreau (2015)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 26
E. Lesky (1973)
Viennese serological research about the year 1900: its contribution to the development of clinical medicine.Bulletin of the New York Academy of Medicine, 49 2
B. Barlogie, L. Smallwood, Terry Smith, R. Alexanian (1989)
High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma.Annals of internal medicine, 110 7
K. Guleria, H. Singh, H. Kaur, V. Sambyal (2005)
ABO Blood Groups in Gastrointestinal Tract (GIT) and Breast Carcinoma PatientsThe Anthropologist, 7
J. Bird, R. Owen, S. D’Sa, J. Snowden, G. Pratt, J. Ashcroft, K. Yong, G. Cook, S. Feyler, F. Davies, G. Morgan, J. Cavenagh, E. Low, J. Behrens (2011)
Guidelines for the diagnosis and management of multiple myeloma 2011British Journal of Haematology, 154
B. Wolpin, A. Chan, P. Hartge, S. Chanock, P. Kraft, D. Hunter, E. Giovannucci, C. Fuchs (2009)
ABO blood group and the risk of pancreatic cancer.Journal of the National Cancer Institute, 101 6
T. Ohira, M. Cushman, M. Tsai, Y. Zhang, S. Heckbert, N. Zakai, W. Rosamond, A. Folsom (2007)
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE)Journal of Thrombosis and Haemostasis, 5
S. Hakomori, S. Hakomori (1999)
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer.Biochimica et biophysica acta, 1473 1
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Summary Background Multiple myeloma (MM) is a cytogenetically heterogeneous and incurable plasma cell disease with unknown etiology. It is thought that the ABO blood groups may play a role in the etiology of many diseases. The purpose of this study is to determine whether there is a relationship between the ABO blood groups and the development of MM, clinical findings and overall survival. Methods In this single-center, retrospective and observational study, 198 patients with known blood types who diagnosed with MM between January 2012 and June 2020 were included. Results It was shown that individuals with blood group 0 had a significantly lower risk of MM (OR = 0.575, 95% confidence interval 0.416–0.794, P = 0.001). The incidence of extramedullary lesion was significantly higher in those with 0 blood group compared to other blood groups (P = 0.000). Overall survival was significantly shorter in patients with 0 blood group than those without 0 blood group (P = 0.007). Conclusion Individuals with 0 blood group had a lower risk of developing MM. It was determined that having 0 blood group is a predisposing factor for the development of extramedullary lesion in MM patients. However, it was shown that having a blood group of 0 was a very significant prognostic factor for MM patients and was associated with short OS.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 1, 2021
Keywords: oncology; medicine/public health, general
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.